直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

So Much to Say, So Few Pages!

September 05, 2013

Authored and Edited by Rachel L. Emsley

The PTAB’s reluctance to extend the page limit for Covered Business Method Review Petitions (80 pages) has practitioners scrambling for strategies to present all their arguments within the prescribed limits. One strategy parties have employed is to file multiple petitions. To date, there are seven instances where a party has filed a pair of petitions for a Covered Business Method Review on the same patent.

Apple, Inc. filed two sets of petitions (CBM 2013-19/-20; and CBM 2013-21/-23). Filing each set of petitions on the same day, Apple divided its petitions based on the grounds—one petition for 35 U.S.C. §§ 101 and 112 issues, and the other for 35 U.S.C. §§ 102 and 103 (for each of the two patents). The Board has not yet issued a decision on those petitions.

The Board has considered five sets of petitions filed by Liberty Mutual Insurance Company, instituting two complete sets and one petition from the other three sets. Liberty Mutual divided its issues based on prior art references, presenting a distinct set of references in each of its petitions. In its decisions, the PTAB acknowledged the sister-petitions but did not deny such split petitions on procedural grounds. In the three Liberty Mutual sets where the PTAB denied one petition, but instituted the other (CBM 2012-10/-11; CBM 2013-1/-2; and CBM 2013-3/-4), the Board carefully considered the merits of each of the petitions and denied petitions only on substantive grounds.

In the two Liberty mutual sets where the Board instituted both petitions, the Board sanctioned multiple petitions. In one set (CBM 2012-3 and -9), the Board instituted both proceedings even though the petitions were filed two months apart, showing not only that the PTAB will consider multiple petitions on the merits, but will do so regardless of when they are received. In the other set (CBM 2012-2 and -4), the Board recognized that reviews of the same patent may benefit from consideration of multiple petitions on a parallel track. The Board did not formally join the cases, but set a joint hearing and asked that the parties coordinate discovery.

Given the PTAB’s apparent willingness to substantively consider multiple petitions challenging the same patent, petitioners addressing many claims or relying on several prior art references or invalidity theories should consider splitting their petitions in a logical fashion to avoid forgoing strong arguments before the PTAB.

Copyright © 2013 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Charitable

Bridges From School to Work Gala 2026

June 22, 2026

Washington, DC

Charitable

Banding Together 2026

June 18, 2026

Washington, DC

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Articles

Article_D.-Mass-Patent-Litigation-Update-October-2024

D. Mass. Patent Litigation Update: April 2026

June 1, 2026

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

At the PTAB Blog

Before the Holding, the Message: Director Squires Uses Magnolia Medical to Outline PTAB Discretionary Denial Policy Changes

May 20, 2026

Webinar

Changes at the PTAB from Settled Expectations to Real Parties in Interest to Director Involvement

May 18, 2026

Webinar

Articles

COPPA’s Amended Rule Is Now in Full Effect: What Operators Need to Know

May 15, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP